From NVIDIA: 2025-04-16 12:00:00

Isomorphic Labs is revolutionizing drug discovery with an AI-first approach, viewing biology as an information processing system. By building generalizable AI models, they are rethinking how drugs are discovered and accelerating the process with exceptional accuracy in predicting molecular interactions. The goal is precision medicine tailored to individual genetic makeup. Max Jaderberg and Sergei Yakneen are committed to proving their technology through real-world pharmaceutical breakthroughs.

On the NVIDIA AI Podcast, Jacob Liberman discusses agentic AI, enabling developers to create intelligent multi-agent systems for practical enterprise applications. Roboflow simplifies computer vision development, empowering users in manufacturing, healthcare, and automotive industries to solve complex problems with visual AI. Ming-Yu Liu explains how world foundation models will advance physical AI by accurately simulating real-world environments for the next generation of AI systems.



Read more at NVIDIA: Isomorphic Labs Rethinks Drug Discovery With AI